Therapy-resistant focal and segmental glomerulosclerosis

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 5, 2003, Pages

  Kveder, Radoslav ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Alkylating agents; Calcineurin inhibitors; Corticosteroids; Nephrotic syndrome; Plasmapheresis; Primary focal and segmental glomerulosclerosis

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; SIMVASTATIN; STEROID; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CATARACT; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; DATA ANALYSIS; DEPRESSION; DIARRHEA; DIET THERAPY; DISEASE COURSE; DRUG USE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LONG TERM CARE; MYOPATHY; NAUSEA; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; STEROID THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; VOMITING;

ADOLESCENT; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PLASMAPHERESIS; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 0041310014     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Korbet SM. Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 1999; 15 [Suppl 3]: 68-73
2. Bolton WK, Abdel-Rahman E. Pathogenesis of focal glomerulosclerosis. Nephron 2001; 88: 6-13
3. Rydell JJ, Korbet SM, Borok RZ, Schwartz MM. Focal glomerular sclerosis in adults: presentation, course and response to treatment. Am J Kidney Dis 1995; 25: 534-542
4. Ponticelli C, Villa M, Banfi G et al. Can prolonged treatment improve prognosis in adults with focal segmental glomerulosclerosis. Am J Kidney Dis 1999; 34: 618-624
5. Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002; 62: 2301-2310
6. Alexopulos E, Stangou M, Papagianni A et al. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15: 1348-1356
7. Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int 1999; 55 [Suppl 70]: S26-S32
8. Meyrier. Treatment of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 1999; 15 [Suppl 3]: 74-78
9. Cattran DC, Appel GB, Herbert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal glomerulosclerosis. Kidney Int 1999; 56: 2220-2226
10. Segarra A, Vila J, Pou L et al. Combined treatment of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002; 17: 655-662
11. Mitwalli AH. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant 1998; 13: 1524-1528
12. Haas M, Godfrin Y, Oberauer R et al. Plasma immunoadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 1998; 13: 2013-2016
13. Briggs WA, Choi MJ, Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. J Am Soc Nephrol 1998; 31: 213-217
14. Choi MJ, Eustace JA, Gimenez LF et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002; 61: 1098-1114
15. Stiles KP, Abbott KC, Welch PG, Yuan CM. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic. Clin Nephrol 2001; 56: 89-95